Sign in Sign up for free

Last updated: 2 August 2024 at 9:51pm EST

Chad Campbell Net Worth




The estimated Net Worth of Chad Thomas Campbell is at least $1.6 Million dollars as of 17 July 2024. Mr. Campbell owns over 6,600 units of Angiodynamic Inc stock worth over $520,788 and over the last 7 years he sold ANGO stock worth over $0. In addition, he makes $1,078,290 as Senior Vice President and General Manager and Vascular Access at Angiodynamic Inc.

Mr. Campbell ANGO stock SEC Form 4 insiders trading

Chad has made over 6 trades of the Angiodynamic Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 6,600 units of ANGO stock worth $48,972 on 17 July 2024.

The largest trade he's ever made was exercising 10,748 units of Angiodynamic Inc stock on 5 October 2021 worth over $178,309. On average, Chad trades about 997 units every 61 days since 2017. As of 17 July 2024 he still owns at least 70,187 units of Angiodynamic Inc stock.

You can see the complete history of Mr. Campbell stock trades at the bottom of the page.





Chad Campbell biography

Chad T. Campbell serves as Senior Vice President and General Manager, Vascular Access of the Company. He joined AngioDynamics in May 2016 as the Senior Vice President and General Manager for the Vascular Access Global Business Unit. In his role, Mr. Campbell oversees research and development and global commercialization of the Global Business Unit’s portfolio. Mr. Campbell joined AngioDynamics from Medtronic where he served as the Vice President of Marketing for the Patient Care and Safety business after serving as the Vice President of Marketing for the SharpSafety business at Covidien (Medtronic). During his tenure at Covidien, Mr. Campbell also held roles including Director of Marketing, Area Vice President of Sales, Region Manager, Product Manager and Account Manager. Mr. Campbell received a Bachelor of Arts from the University of Kentucky.

What is the salary of Chad Campbell?

As the Senior Vice President and General Manager and Vascular Access of Angiodynamic Inc, the total compensation of Chad Campbell at Angiodynamic Inc is $1,078,290. There are 2 executives at Angiodynamic Inc getting paid more, with James Clemmer having the highest compensation of $3,116,630.



How old is Chad Campbell?

Chad Campbell is 49, he's been the Senior Vice President and General Manager and Vascular Access of Angiodynamic Inc since 2016. There are 22 older and 4 younger executives at Angiodynamic Inc. The oldest executive at Angiodynamic Inc is Dennis Meteny, 67, who is the Independent Director.

What's Chad Campbell's mailing address?

Chad's mailing address filed with the SEC is 14 PLAZA DRIVE, , LATHAM, NY, 12110.

Insiders trading at Angiodynamic Inc

Over the last 20 years, insiders at Angiodynamic Inc have traded over $207,843,757 worth of Angiodynamic Inc stock and bought 255,612 units worth $3,086,102 . The most active insiders traders include David F Burgstahler, Sriram Venkataraman, and Capital Partners Gp, Llc Av.... On average, Angiodynamic Inc executives and independent directors trade stock every 36 days with the average trade being worth of $826,492. The most recent stock trade was executed by Laura Piccinini on 17 July 2024, trading 4,439 units of ANGO stock currently worth $32,937.



What does Angiodynamic Inc do?

founded in 1988 in queensbury, n.y., u.s., angiodynamics is today a nasdaq-listed public company. we are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. our diverse product line includes market-leading radiofrequency ablation and nanoknife® systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. angiodynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the company’s consistent ability to successfully develop and bring to market new technologies and products. angiodynamics believes it is well poised to continue that trend. looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patie



What does Angiodynamic Inc's logo look like?

Angiodynamic Inc logo

Complete history of Mr. Campbell stock trades at Angiodynamic Inc

Date
#
Company
 Insider
Trans.
Transaction
 Shares Price per share Total value Shares after Source
17 Jul 2024 ANGO Angiodynamic Inc Chad Thomas Campbell
SVP/GM and Vascular Access
 Option 6,600 $7.40 $48,840
17 Jul 2024
70,187 ↗
19 Jul 2023 ANGO Angiodynamic Inc Chad Thomas Campbell
SVP/GM and Vascular Access
 Option 3,900 $8.92 $34,788
19 Jul 2023
51,409 ↗
7 Jul 2022 ANGO Angiodynamic Inc Chad Thomas Campbell
SVP/GM and Vascular Access
 Option 3,104 $20.54 $63,756
7 Jul 2022
34,845 ↗
5 Oct 2021 ANGO Angiodynamic Inc Chad Thomas Campbell
SVP/GM and Vascular Access
 Option 10,748 $16.59 $178,309
5 Oct 2021
42,489 ↗
12 Aug 2021 ANGO Angiodynamic Inc Chad Thomas Campbell
SVP/GM and Vascular Access
 Option 2,395 $27.29 $65,360
12 Aug 2021
29,056 ↗
12 Jul 2019 ANGO Angiodynamic Inc Chad Thomas Campbell
SVP/GM and Vascular Access
 Option 3,174 $21.68 $68,812
12 Jul 2019
22,102 ↗


Angiodynamic Inc executives and stock owners

Angiodynamic Inc executives and other stock owners filed with the SEC include: